We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Boston to Host Drug Discovery World Congress

By Biotechdaily staff writers
Posted on 18 Jul 2002
The Drug Discovery Technology World Congress, to be held in Boston, (MA, USA) August 4-9, 2002, is the world's leading conference and exposition to provide information about the newest drug discovery techniques and applications. More...
More than 5,000 scientists and business leaders are expected to attend. The event will be held in the Hynes Convention Center.

The congress is designed to help drug-discovery researchers and business executive to evaluate and understand the latest advances and information in drug discovery. Leaders from the pharmaceutical, biotechnology, academic, and government sectors will attend.

Specific topics to be covered in the information technology sessions include: the convergence of IT and drug discovery, data integration and knowledge management, creating a bioinformatics infrastructure, and data visualization and data mining. The full-day IT forum will be held on Monday, August 5, while the mini-tutorials will be held on August 6 and 7. A new session this year, called "Start-Up Showcase: Emerging and Early Stage Companies,” will be held on Sunday, August 4.

More than 350 booths will showcase the latest products and services, and over 90 companies will be launching a new product at the congress. More information is available on the show's website. The congress is produced by IBC Life Sciences (Westborough, MA, USA).



Related Links:
The Drug Discovery Technology World Congress

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Immunoassay Analyzer
Procise DX
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.